nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—CASP10—melanoma	0.0292	0.0669	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—RAI1—melanoma	0.0275	0.0629	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—APAF1—melanoma	0.0262	0.06	CbGpPWpGaD
Sodium stibogluconate—Bronchopneumonia—Docetaxel—melanoma	0.018	0.0319	CcSEcCtD
Sodium stibogluconate—Clotting—Temozolomide—melanoma	0.0165	0.0293	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—ARNT—melanoma	0.0163	0.0374	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PAX4—melanoma	0.0158	0.0361	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.0155	0.0354	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—FASLG—melanoma	0.0128	0.0293	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.0125	0.0285	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—FAS—melanoma	0.0123	0.0283	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.0111	0.0254	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.0111	0.0254	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.0103	0.0235	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.00996	0.0228	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—CASP8—melanoma	0.00952	0.0218	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.00944	0.0216	CbGpPWpGaD
Sodium stibogluconate—Coagulopathy—Dactinomycin—melanoma	0.00837	0.0149	CcSEcCtD
Sodium stibogluconate—Lung disorder—Temozolomide—melanoma	0.00833	0.0148	CcSEcCtD
Sodium stibogluconate—Necrosis—Dactinomycin—melanoma	0.0083	0.0147	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—BCL2—melanoma	0.00817	0.0187	CbGpPWpGaD
Sodium stibogluconate—Extravasation—Bleomycin—melanoma	0.00801	0.0142	CcSEcCtD
Sodium stibogluconate—Tenderness—Bleomycin—melanoma	0.00801	0.0142	CcSEcCtD
Sodium stibogluconate—Necrosis—Carmustine—melanoma	0.00777	0.0138	CcSEcCtD
Sodium stibogluconate—Abscess—Carmustine—melanoma	0.00771	0.0137	CcSEcCtD
Sodium stibogluconate—Coagulopathy—Temozolomide—melanoma	0.00757	0.0134	CcSEcCtD
Sodium stibogluconate—Extravasation—Dactinomycin—melanoma	0.00747	0.0133	CcSEcCtD
Sodium stibogluconate—Ulcer—Bleomycin—melanoma	0.00739	0.0131	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—CASP3—melanoma	0.0072	0.0165	CbGpPWpGaD
Sodium stibogluconate—Hypocalcaemia—Dactinomycin—melanoma	0.00712	0.0126	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—GNA11—melanoma	0.00705	0.0161	CbGpPWpGaD
Sodium stibogluconate—Extravasation—Carmustine—melanoma	0.00699	0.0124	CcSEcCtD
Sodium stibogluconate—Ulcer—Dactinomycin—melanoma	0.00689	0.0122	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—HDAC2—melanoma	0.00663	0.0152	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—GNAQ—melanoma	0.00655	0.015	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—NGFR—melanoma	0.00605	0.0139	CbGpPWpGaD
Sodium stibogluconate—Phlebitis—Bleomycin—melanoma	0.00589	0.0105	CcSEcCtD
Sodium stibogluconate—Intestinal obstruction—Docetaxel—melanoma	0.00575	0.0102	CcSEcCtD
Sodium stibogluconate—Disorientation—Bleomycin—melanoma	0.00567	0.0101	CcSEcCtD
Sodium stibogluconate—Sepsis—Dactinomycin—melanoma	0.00566	0.01	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.00552	0.0126	CbGpPWpGaD
Sodium stibogluconate—Phlebitis—Dactinomycin—melanoma	0.00549	0.00975	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.00539	0.0123	CbGpPWpGaD
Sodium stibogluconate—Sepsis—Carmustine—melanoma	0.00529	0.0094	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNF—melanoma	0.00524	0.012	CbGpPWpGaD
Sodium stibogluconate—Cerebrovascular accident—Bleomycin—melanoma	0.00518	0.00919	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.00517	0.0118	CbGpPWpGaD
Sodium stibogluconate—Phlebitis—Carmustine—melanoma	0.00514	0.00912	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.00506	0.0116	CbGpPWpGaD
Sodium stibogluconate—Swelling—Carmustine—melanoma	0.00502	0.00891	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.00501	0.0115	CbGpPWpGaD
Sodium stibogluconate—Necrosis—Docetaxel—melanoma	0.00499	0.00887	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.00496	0.0114	CbGpPWpGaD
Sodium stibogluconate—Dysgeusia—Vemurafenib—melanoma	0.00494	0.00876	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00486	0.0111	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.00477	0.0109	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.00469	0.0107	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.0046	0.0105	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—FAS—melanoma	0.0045	0.0103	CbGpPWpGaD
Sodium stibogluconate—Extravasation—Docetaxel—melanoma	0.00449	0.00798	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Carmustine—melanoma	0.00445	0.00789	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.00437	0.01	CbGpPWpGaD
Sodium stibogluconate—Bronchospasm—Bleomycin—melanoma	0.00431	0.00766	CcSEcCtD
Sodium stibogluconate—Oliguria—Docetaxel—melanoma	0.00425	0.00755	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.00414	0.00949	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.00413	0.00945	CbGpPWpGaD
Sodium stibogluconate—Anaphylactic shock—Vemurafenib—melanoma	0.00412	0.0073	CcSEcCtD
Sodium stibogluconate—Dysphagia—Dactinomycin—melanoma	0.00409	0.00726	CcSEcCtD
Sodium stibogluconate—Infection—Vemurafenib—melanoma	0.00409	0.00726	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Carmustine—melanoma	0.00403	0.00715	CcSEcCtD
Sodium stibogluconate—Dehydration—Temozolomide—melanoma	0.00398	0.00706	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—CDK4—melanoma	0.00396	0.00907	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—AKT1—melanoma	0.0039	0.00893	CbGpPWpGaD
Sodium stibogluconate—Hypokalaemia—Temozolomide—melanoma	0.00389	0.00691	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.00388	0.0089	CbGpPWpGaD
Sodium stibogluconate—Acute coronary syndrome—Bleomycin—melanoma	0.00385	0.00684	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—NOS2—melanoma	0.00385	0.00882	CbGpPWpGaD
Sodium stibogluconate—Hypotension—Vemurafenib—melanoma	0.00385	0.00683	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.00384	0.00879	CbGpPWpGaD
Sodium stibogluconate—Myocardial infarction—Bleomycin—melanoma	0.00383	0.0068	CcSEcCtD
Sodium stibogluconate—Dysphagia—Carmustine—melanoma	0.00383	0.00679	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Temozolomide—melanoma	0.00372	0.00661	CcSEcCtD
Sodium stibogluconate—Fluid retention—Docetaxel—melanoma	0.00372	0.00661	CcSEcCtD
Sodium stibogluconate—Dysphagia—Temozolomide—melanoma	0.0037	0.00656	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.00362	0.00829	CbGpPWpGaD
Sodium stibogluconate—Sweating increased—Temozolomide—melanoma	0.0036	0.00639	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PPARG—melanoma	0.0036	0.00824	CbGpPWpGaD
Sodium stibogluconate—Decreased appetite—Vemurafenib—melanoma	0.00358	0.00635	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.00356	0.00815	CbGpPWpGaD
Sodium stibogluconate—Bronchitis—Temozolomide—melanoma	0.00356	0.00631	CcSEcCtD
Sodium stibogluconate—Fatigue—Vemurafenib—melanoma	0.00355	0.0063	CcSEcCtD
Sodium stibogluconate—Constipation—Vemurafenib—melanoma	0.00352	0.00625	CcSEcCtD
Sodium stibogluconate—Lightheadedness—Docetaxel—melanoma	0.00351	0.00623	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Bleomycin—melanoma	0.00349	0.0062	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00344	0.00787	CbGpPWpGaD
Sodium stibogluconate—Sepsis—Docetaxel—melanoma	0.0034	0.00604	CcSEcCtD
Sodium stibogluconate—Renal failure—Carmustine—melanoma	0.00335	0.00595	CcSEcCtD
Sodium stibogluconate—Phlebitis—Docetaxel—melanoma	0.0033	0.00586	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.00327	0.00749	CbGpPWpGaD
Sodium stibogluconate—Body temperature increased—Vemurafenib—melanoma	0.00325	0.00577	CcSEcCtD
Sodium stibogluconate—Swelling—Docetaxel—melanoma	0.00323	0.00573	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Docetaxel—melanoma	0.00314	0.00557	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.00311	0.00711	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.00306	0.00701	CbGpPWpGaD
Sodium stibogluconate—Hypoaesthesia—Carmustine—melanoma	0.00305	0.00541	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Vemurafenib—melanoma	0.00303	0.00538	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.00302	0.00691	CbGpPWpGaD
Sodium stibogluconate—Renal impairment—Docetaxel—melanoma	0.00299	0.00531	CcSEcCtD
Sodium stibogluconate—Asthenia—Vemurafenib—melanoma	0.00295	0.00524	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00295	0.00676	CbGpPWpGaD
Sodium stibogluconate—Hypoaesthesia—Temozolomide—melanoma	0.00295	0.00523	CcSEcCtD
Sodium stibogluconate—Pruritus—Vemurafenib—melanoma	0.00291	0.00517	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Docetaxel—melanoma	0.00286	0.00507	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Vemurafenib—melanoma	0.00282	0.005	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.00279	0.0064	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.00274	0.00627	CbGpPWpGaD
Sodium stibogluconate—Arrhythmia—Carmustine—melanoma	0.00274	0.00486	CcSEcCtD
Sodium stibogluconate—Dizziness—Vemurafenib—melanoma	0.00272	0.00483	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.00267	0.0061	CbGpPWpGaD
Sodium stibogluconate—Dehydration—Docetaxel—melanoma	0.00265	0.0047	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.00264	0.00604	CbGpPWpGaD
Sodium stibogluconate—Vomiting—Vemurafenib—melanoma	0.00262	0.00464	CcSEcCtD
Sodium stibogluconate—Chest pain—Bleomycin—melanoma	0.0026	0.00462	CcSEcCtD
Sodium stibogluconate—Rash—Vemurafenib—melanoma	0.00259	0.00461	CcSEcCtD
Sodium stibogluconate—Dermatitis—Vemurafenib—melanoma	0.00259	0.0046	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.00258	0.0059	CbGpPWpGaD
Sodium stibogluconate—Headache—Vemurafenib—melanoma	0.00258	0.00458	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.00257	0.00589	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.00256	0.00586	CbGpPWpGaD
Sodium stibogluconate—Dysgeusia—Temozolomide—melanoma	0.00252	0.00448	CcSEcCtD
Sodium stibogluconate—Vision blurred—Carmustine—melanoma	0.00251	0.00446	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Bleomycin—melanoma	0.00249	0.00443	CcSEcCtD
Sodium stibogluconate—Oedema—Bleomycin—melanoma	0.00249	0.00443	CcSEcCtD
Sodium stibogluconate—Infection—Bleomycin—melanoma	0.00248	0.0044	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PTEN—melanoma	0.00247	0.00566	CbGpPWpGaD
Sodium stibogluconate—Dysphagia—Docetaxel—melanoma	0.00246	0.00437	CcSEcCtD
Sodium stibogluconate—Nausea—Vemurafenib—melanoma	0.00244	0.00434	CcSEcCtD
Sodium stibogluconate—Vision blurred—Temozolomide—melanoma	0.00243	0.00431	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Docetaxel—melanoma	0.00242	0.00429	CcSEcCtD
Sodium stibogluconate—Anorexia—Bleomycin—melanoma	0.00238	0.00422	CcSEcCtD
Sodium stibogluconate—Hypotension—Bleomycin—melanoma	0.00233	0.00414	CcSEcCtD
Sodium stibogluconate—Oedema—Dactinomycin—melanoma	0.00233	0.00413	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.00232	0.00532	CbGpPWpGaD
Sodium stibogluconate—Convulsion—Carmustine—melanoma	0.00231	0.0041	CcSEcCtD
Sodium stibogluconate—Infection—Dactinomycin—melanoma	0.00231	0.0041	CcSEcCtD
Sodium stibogluconate—Palpitations—Temozolomide—melanoma	0.00228	0.00404	CcSEcCtD
Sodium stibogluconate—Chest pain—Carmustine—melanoma	0.00227	0.00403	CcSEcCtD
Sodium stibogluconate—Anxiety—Carmustine—melanoma	0.00226	0.00402	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Bleomycin—melanoma	0.00224	0.00397	CcSEcCtD
Sodium stibogluconate—Convulsion—Temozolomide—melanoma	0.00223	0.00396	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Bleomycin—melanoma	0.00222	0.00395	CcSEcCtD
Sodium stibogluconate—Anorexia—Dactinomycin—melanoma	0.00222	0.00393	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.0022	0.00503	CbGpPWpGaD
Sodium stibogluconate—Anxiety—Temozolomide—melanoma	0.00219	0.00388	CcSEcCtD
Sodium stibogluconate—Oedema—Carmustine—melanoma	0.00218	0.00386	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Bleomycin—melanoma	0.00217	0.00385	CcSEcCtD
Sodium stibogluconate—Infection—Carmustine—melanoma	0.00216	0.00384	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Docetaxel—melanoma	0.00216	0.00384	CcSEcCtD
Sodium stibogluconate—Renal failure—Docetaxel—melanoma	0.00216	0.00383	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Docetaxel—melanoma	0.00215	0.00382	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.00214	0.0049	CbGpPWpGaD
Sodium stibogluconate—Tachycardia—Carmustine—melanoma	0.00212	0.00377	CcSEcCtD
Sodium stibogluconate—Oedema—Temozolomide—melanoma	0.0021	0.00373	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Temozolomide—melanoma	0.0021	0.00373	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.00209	0.00479	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.00209	0.00479	CbGpPWpGaD
Sodium stibogluconate—Infection—Temozolomide—melanoma	0.00209	0.00371	CcSEcCtD
Sodium stibogluconate—Anorexia—Carmustine—melanoma	0.00207	0.00368	CcSEcCtD
Sodium stibogluconate—Hypotension—Carmustine—melanoma	0.00203	0.00361	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Temozolomide—melanoma	0.00203	0.00361	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Dactinomycin—melanoma	0.00202	0.00359	CcSEcCtD
Sodium stibogluconate—Fatigue—Dactinomycin—melanoma	0.002	0.00356	CcSEcCtD
Sodium stibogluconate—Anorexia—Temozolomide—melanoma	0.002	0.00356	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.00199	0.00456	CbGpPWpGaD
Sodium stibogluconate—Urticaria—Bleomycin—melanoma	0.00198	0.00352	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.00198	0.00452	CbGpPWpGaD
Sodium stibogluconate—Body temperature increased—Bleomycin—melanoma	0.00197	0.0035	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Docetaxel—melanoma	0.00196	0.00348	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Carmustine—melanoma	0.00195	0.00347	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Carmustine—melanoma	0.00194	0.00344	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Dactinomycin—melanoma	0.0019	0.00338	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Carmustine—melanoma	0.00189	0.00336	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Temozolomide—melanoma	0.00189	0.00335	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Temozolomide—melanoma	0.00187	0.00333	CcSEcCtD
Sodium stibogluconate—Constipation—Carmustine—melanoma	0.00186	0.0033	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Dactinomycin—melanoma	0.00184	0.00326	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Dactinomycin—melanoma	0.00184	0.00326	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Bleomycin—melanoma	0.00184	0.00326	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Temozolomide—melanoma	0.00183	0.00325	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.00181	0.00416	CbGpPWpGaD
Sodium stibogluconate—Fatigue—Temozolomide—melanoma	0.00181	0.00322	CcSEcCtD
Sodium stibogluconate—Constipation—Temozolomide—melanoma	0.0018	0.00319	CcSEcCtD
Sodium stibogluconate—Asthenia—Bleomycin—melanoma	0.00179	0.00318	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Carmustine—melanoma	0.00178	0.00316	CcSEcCtD
Sodium stibogluconate—Pruritus—Bleomycin—melanoma	0.00176	0.00313	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Docetaxel—melanoma	0.00176	0.00312	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.00176	0.00402	CbGpPWpGaD
Sodium stibogluconate—Abdominal pain—Carmustine—melanoma	0.00172	0.00305	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Carmustine—melanoma	0.00172	0.00305	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Temozolomide—melanoma	0.00172	0.00305	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Dactinomycin—melanoma	0.00171	0.00304	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TP53—melanoma	0.00169	0.00386	CbGpPWpGaD
Sodium stibogluconate—Dysgeusia—Docetaxel—melanoma	0.00168	0.00298	CcSEcCtD
Sodium stibogluconate—Urticaria—Temozolomide—melanoma	0.00167	0.00297	CcSEcCtD
Sodium stibogluconate—Asthenia—Dactinomycin—melanoma	0.00167	0.00296	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Temozolomide—melanoma	0.00166	0.00295	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Temozolomide—melanoma	0.00166	0.00295	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Carmustine—melanoma	0.0016	0.00285	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Dactinomycin—melanoma	0.00159	0.00282	CcSEcCtD
Sodium stibogluconate—Vomiting—Bleomycin—melanoma	0.00159	0.00281	CcSEcCtD
Sodium stibogluconate—Rash—Bleomycin—melanoma	0.00157	0.00279	CcSEcCtD
Sodium stibogluconate—Dermatitis—Bleomycin—melanoma	0.00157	0.00279	CcSEcCtD
Sodium stibogluconate—Asthenia—Carmustine—melanoma	0.00156	0.00277	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Temozolomide—melanoma	0.00155	0.00275	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—IL6—melanoma	0.00154	0.00353	CbGpPWpGaD
Sodium stibogluconate—Syncope—Docetaxel—melanoma	0.00154	0.00273	CcSEcCtD
Sodium stibogluconate—Palpitations—Docetaxel—melanoma	0.00151	0.00269	CcSEcCtD
Sodium stibogluconate—Asthenia—Temozolomide—melanoma	0.00151	0.00268	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Docetaxel—melanoma	0.00151	0.00267	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Carmustine—melanoma	0.00149	0.00264	CcSEcCtD
Sodium stibogluconate—Pruritus—Temozolomide—melanoma	0.00149	0.00264	CcSEcCtD
Sodium stibogluconate—Convulsion—Docetaxel—melanoma	0.00148	0.00264	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.00148	0.0034	CbGpPWpGaD
Sodium stibogluconate—Nausea—Bleomycin—melanoma	0.00148	0.00263	CcSEcCtD
Sodium stibogluconate—Vomiting—Dactinomycin—melanoma	0.00148	0.00262	CcSEcCtD
Sodium stibogluconate—Rash—Dactinomycin—melanoma	0.00147	0.0026	CcSEcCtD
Sodium stibogluconate—Chest pain—Docetaxel—melanoma	0.00146	0.00259	CcSEcCtD
Sodium stibogluconate—Dizziness—Carmustine—melanoma	0.00144	0.00255	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Temozolomide—melanoma	0.00144	0.00255	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Docetaxel—melanoma	0.0014	0.00248	CcSEcCtD
Sodium stibogluconate—Oedema—Docetaxel—melanoma	0.0014	0.00248	CcSEcCtD
Sodium stibogluconate—Dizziness—Temozolomide—melanoma	0.00139	0.00247	CcSEcCtD
Sodium stibogluconate—Infection—Docetaxel—melanoma	0.00139	0.00247	CcSEcCtD
Sodium stibogluconate—Vomiting—Carmustine—melanoma	0.00138	0.00246	CcSEcCtD
Sodium stibogluconate—Nausea—Dactinomycin—melanoma	0.00138	0.00245	CcSEcCtD
Sodium stibogluconate—Shock—Docetaxel—melanoma	0.00138	0.00244	CcSEcCtD
Sodium stibogluconate—Rash—Carmustine—melanoma	0.00137	0.00244	CcSEcCtD
Sodium stibogluconate—Dermatitis—Carmustine—melanoma	0.00137	0.00243	CcSEcCtD
Sodium stibogluconate—Tachycardia—Docetaxel—melanoma	0.00136	0.00242	CcSEcCtD
Sodium stibogluconate—Headache—Carmustine—melanoma	0.00136	0.00242	CcSEcCtD
Sodium stibogluconate—Vomiting—Temozolomide—melanoma	0.00134	0.00237	CcSEcCtD
Sodium stibogluconate—Anorexia—Docetaxel—melanoma	0.00133	0.00237	CcSEcCtD
Sodium stibogluconate—Rash—Temozolomide—melanoma	0.00133	0.00235	CcSEcCtD
Sodium stibogluconate—Dermatitis—Temozolomide—melanoma	0.00132	0.00235	CcSEcCtD
Sodium stibogluconate—Headache—Temozolomide—melanoma	0.00132	0.00234	CcSEcCtD
Sodium stibogluconate—Hypotension—Docetaxel—melanoma	0.00131	0.00232	CcSEcCtD
Sodium stibogluconate—Nausea—Carmustine—melanoma	0.00129	0.00229	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Docetaxel—melanoma	0.00126	0.00223	CcSEcCtD
Sodium stibogluconate—Nausea—Temozolomide—melanoma	0.00125	0.00222	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Docetaxel—melanoma	0.00125	0.00221	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Docetaxel—melanoma	0.00122	0.00216	CcSEcCtD
Sodium stibogluconate—Fatigue—Docetaxel—melanoma	0.00121	0.00214	CcSEcCtD
Sodium stibogluconate—Constipation—Docetaxel—melanoma	0.0012	0.00212	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Docetaxel—melanoma	0.00114	0.00203	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Docetaxel—melanoma	0.00111	0.00196	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Docetaxel—melanoma	0.00111	0.00196	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Docetaxel—melanoma	0.00103	0.00183	CcSEcCtD
Sodium stibogluconate—Asthenia—Docetaxel—melanoma	0.001	0.00178	CcSEcCtD
Sodium stibogluconate—Pruritus—Docetaxel—melanoma	0.00099	0.00176	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Docetaxel—melanoma	0.000957	0.0017	CcSEcCtD
Sodium stibogluconate—Dizziness—Docetaxel—melanoma	0.000925	0.00164	CcSEcCtD
Sodium stibogluconate—Vomiting—Docetaxel—melanoma	0.000889	0.00158	CcSEcCtD
Sodium stibogluconate—Rash—Docetaxel—melanoma	0.000882	0.00157	CcSEcCtD
Sodium stibogluconate—Dermatitis—Docetaxel—melanoma	0.000881	0.00156	CcSEcCtD
Sodium stibogluconate—Headache—Docetaxel—melanoma	0.000876	0.00156	CcSEcCtD
Sodium stibogluconate—Nausea—Docetaxel—melanoma	0.000831	0.00147	CcSEcCtD
